Clinical Trial Update: Cerclage for Prevention on Preterm Birth in Women With Placenta Previa [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cerclage to prevent preterm birth in women with placenta previa has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Placenta Previa
• Preterm Birth

Snippet

Sponsor: Obstetrix Medical Group | Conditions: Premature Birth, Placenta Previa | Phase 3 | Status: WITHDRAWN